FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103604711> ?p ?o ?g. }

• W2103604711 endingPage "625" @default.
• W2103604711 startingPage "618" @default.
• W2103604711 abstract "BACKGROUND AND OBJECTIVE Facial rhytides are a common cosmetic concern. Surgical treatment effects dramatic improvement; however, the associated risk and cost may be prohibitive. Recent focus is on developing topical products containing biologically active ingredients for at-home therapy. Our study examines the effects of a topical cream containing transforming growth factor-β1 (TGF-β1), L-ascorbic acid, and Cimicifuga racemosa extract (CRS) (Topix Pharmaceuticals, North Amityville, NY, USA). MATERIALS AND METHODS In the first arm of the study, 12 subjects were randomized to apply CRS to the left or right side of their face and a cream containing L-ascorbic acid and C. racemosa in silicone base (vitamin C [Vit C]) to the contralateral side twice daily for 3 months. In the second arm of the study, 20 subjects were randomized to apply CRS to the left or right side of their face and Tissue Nutrient Solution Recovery Complex (TNS) (SkinMedica, Carlsbad, CA, USA), a product containing a variety of growth factors including VEGF, PDGF-A, G-CSF, HGF, IL-6, IL-8, and TGF-β1 (Nouricel-MD) without L-ascorbic acid, C. racemosa extract, or silicone base, to the contralateral side of their face twice daily for 3 months. Digital photographs were scored by study-blinded physicians, and self-assessments were completed by all subjects at baseline and at the conclusion of the protocol. RESULTS CRS and TNS were well tolerated, and all subjects completed the 3-month protocol for the CRS versus Vit C arm of the study. Physicians rated success in facial wrinkling scores on the CRS-treated side of the face for 27 of 31 subjects. Responders showed, on average, 21.7% improvement in physician-rated wrinkle scores. The mean improvement in the group of 31 patients as a whole was 12%. Eighteen of 31 subjects reported a noticeable improvement on their CRS-treated side. Both CRS and TNS demonstrate significant success between baseline and 3-month scores, and both growth factor products are superior to Vit C. Patients preferred CRS over TNS. CONCLUSION CRS is effective in minimizing the appearance of facial rhytides. The success of the CRS product is largely attributable to the incorporation of TGF-β1." @default.
• W2103604711 created "2016-06-24" @default.
• W2103604711 creator A5027929697 @default.
• W2103604711 creator A5060607144 @default.
• W2103604711 creator A5066694443 @default.
• W2103604711 creator A5069203816 @default.
• W2103604711 date "2006-05-01" @default.
• W2103604711 modified "2023-10-12" @default.
• W2103604711 title "Improvement in the Appearance of Wrinkles with Topical Transforming Growth Factor beta1 and l-Ascorbic Acid" @default.
• W2103604711 cites W192475670 @default.
• W2103604711 cites W1966223430 @default.
• W2103604711 cites W1968441331 @default.
• W2103604711 cites W1978504010 @default.
• W2103604711 cites W1986063342 @default.
• W2103604711 cites W1987707948 @default.
• W2103604711 cites W1988224726 @default.
• W2103604711 cites W1994972521 @default.
• W2103604711 cites W2004460833 @default.
• W2103604711 cites W2011004925 @default.
• W2103604711 cites W2023420172 @default.
• W2103604711 cites W2024882159 @default.
• W2103604711 cites W2036118869 @default.
• W2103604711 cites W2043280666 @default.
• W2103604711 cites W2053002867 @default.
• W2103604711 cites W2065161640 @default.
• W2103604711 cites W2072035390 @default.
• W2103604711 cites W2082728252 @default.
• W2103604711 cites W2090642916 @default.
• W2103604711 cites W2090913089 @default.
• W2103604711 cites W2093210435 @default.
• W2103604711 cites W2101202695 @default.
• W2103604711 cites W2101426425 @default.
• W2103604711 cites W2128756814 @default.
• W2103604711 cites W2152056185 @default.
• W2103604711 cites W4243715554 @default.
• W2103604711 cites W4246533358 @default.
• W2103604711 doi "https://doi.org/10.1111/j.1524-4725.2006.32132.x" @default.
• W2103604711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16706755" @default.
• W2103604711 hasPublicationYear "2006" @default.
• W2103604711 type Work @default.
• W2103604711 sameAs 2103604711 @default.
• W2103604711 citedByCount "31" @default.
• W2103604711 countsByYear W21036047112012 @default.
• W2103604711 countsByYear W21036047112013 @default.
• W2103604711 countsByYear W21036047112015 @default.
• W2103604711 countsByYear W21036047112016 @default.
• W2103604711 countsByYear W21036047112017 @default.
• W2103604711 countsByYear W21036047112018 @default.
• W2103604711 countsByYear W21036047112019 @default.
• W2103604711 countsByYear W21036047112020 @default.
• W2103604711 countsByYear W21036047112023 @default.
• W2103604711 crossrefType "journal-article" @default.
• W2103604711 hasAuthorship W2103604711A5027929697 @default.
• W2103604711 hasAuthorship W2103604711A5060607144 @default.
• W2103604711 hasAuthorship W2103604711A5066694443 @default.
• W2103604711 hasAuthorship W2103604711A5069203816 @default.
• W2103604711 hasConcept C126322002 @default.
• W2103604711 hasConcept C141071460 @default.
• W2103604711 hasConcept C16005928 @default.
• W2103604711 hasConcept C168563851 @default.
• W2103604711 hasConcept C178790620 @default.
• W2103604711 hasConcept C185592680 @default.
• W2103604711 hasConcept C2776940978 @default.
• W2103604711 hasConcept C2779769944 @default.
• W2103604711 hasConcept C2780022331 @default.
• W2103604711 hasConcept C2986274086 @default.
• W2103604711 hasConcept C31903555 @default.
• W2103604711 hasConcept C71924100 @default.
• W2103604711 hasConceptScore W2103604711C126322002 @default.
• W2103604711 hasConceptScore W2103604711C141071460 @default.
• W2103604711 hasConceptScore W2103604711C16005928 @default.
• W2103604711 hasConceptScore W2103604711C168563851 @default.
• W2103604711 hasConceptScore W2103604711C178790620 @default.
• W2103604711 hasConceptScore W2103604711C185592680 @default.
• W2103604711 hasConceptScore W2103604711C2776940978 @default.
• W2103604711 hasConceptScore W2103604711C2779769944 @default.
• W2103604711 hasConceptScore W2103604711C2780022331 @default.
• W2103604711 hasConceptScore W2103604711C2986274086 @default.
• W2103604711 hasConceptScore W2103604711C31903555 @default.
• W2103604711 hasConceptScore W2103604711C71924100 @default.
• W2103604711 hasIssue "5" @default.
• W2103604711 hasLocation W21036047111 @default.
• W2103604711 hasLocation W21036047112 @default.
• W2103604711 hasOpenAccess W2103604711 @default.
• W2103604711 hasPrimaryLocation W21036047111 @default.
• W2103604711 hasRelatedWork W1557131619 @default.
• W2103604711 hasRelatedWork W2007003590 @default.
• W2103604711 hasRelatedWork W2064638068 @default.
• W2103604711 hasRelatedWork W2115505172 @default.
• W2103604711 hasRelatedWork W2429727963 @default.
• W2103604711 hasRelatedWork W2559972729 @default.
• W2103604711 hasRelatedWork W2883433289 @default.
• W2103604711 hasRelatedWork W2988363766 @default.
• W2103604711 hasRelatedWork W3006227767 @default.
• W2103604711 hasRelatedWork W3110880458 @default.
• W2103604711 hasVolume "32" @default.
• W2103604711 isParatext "false" @default.
• W2103604711 isRetracted "false" @default.

• next